STOCK TITAN

Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

(Neutral)
(Neutral)
Tags

Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) announced it will release its second quarter 2022 financial results on August 2, 2022, before market open. A conference call will follow at 5:30 a.m. PT to discuss results, business developments, and future outlook. Nautilus is focused on developing a single-molecule protein analysis platform aimed at advancing proteomics for improved health and medicine.

Loading...
Loading translation...

Positive

  • Upcoming financial results expected to provide insights into company performance.
  • Management conference call suggests transparency and engagement with investors.

Negative

  • None.

News Market Reaction – NAUT

+1.77%
+1.77% Session move

In the trading session that priced this news, NAUT gained 1.77%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 2nd, 2022.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.

Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media contact
Thermal for Nautilus Biotechnology
Kaustuva Das
press@nautilus.bio

Investor Contact
investorRelations@nautilus.bio


FAQ

When will Nautilus Biotechnology report its Q2 2022 financial results?

Nautilus Biotechnology will report its Q2 2022 financial results on August 2, 2022, before market open.

What time is the conference call for Nautilus's Q2 earnings?

The conference call will begin at 5:30 a.m. PT / 8:30 a.m. ET.

How can I access the webcast for Nautilus's conference call?

The webcast can be accessed via the Investors section on Nautilus's website at www.nautilus.bio.

What is Nautilus Biotechnology's focus in the life sciences sector?

Nautilus is focused on developing a platform for quantifying and unlocking the complexity of the proteome.